Stay updated on Gantenerumab in Early Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab in Early Alzheimer's Disease Clinical Trial page.

Latest updates to the Gantenerumab in Early Alzheimer's Disease Clinical Trial page
- Check2 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5, indicating a newer software revision. There is no indication of changes to visible content or user-facing features based on the provided data.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new ARIA-related publication citation was added to the Publications section (Salloway et al., JAMA Neurol., 2025) and the Erratum entry for that article was removed.SummaryDifference0.0%

- Check38 days agoChange DetectedTaoyuan District, Taiwan, 333 has been replaced with Taoyuan, Taiwan, 333 in the study locations. This updates the geographic entry to reflect the correct city naming for the site.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page’s software/display revision label has been updated from v3.5.2 to v3.5.3, reflecting a site release without altering the clinical trial study details.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded a new ARIA-related publication entry for gantenerumab in early Alzheimer’s disease with an erratum and updated revision to v3.5.2. Removed the earlier ARIA publication entry with revision v3.5.0.SummaryDifference0.0%

- Check81 days agoChange DetectedWebsite version updated from v3.4.3 to v3.5.0, reflecting deployed updates. No study content changes are indicated.SummaryDifference0.0%

Stay in the know with updates to Gantenerumab in Early Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Early Alzheimer's Disease Clinical Trial page.